Home / Wellness technology

Over-the-counter continuous glucose monitor: what to know first

By the Life in Good Form editors. Updated 2026-10-15.

We research products from makers' specs and health sources; we do not run hands-on tests. Links to Amazon may earn us a commission at no cost to you. How this works.

Quick answerAn over-the-counter continuous glucose monitor (CGM) is a small sensor worn on the skin that estimates glucose levels around the clock and sends readings to a phone app, without a prescription. The FDA cleared the first one, Dexcom's Stelo, in March 2024 for adults 18 and older who do not use insulin, and Abbott announced FDA clearance of Lingo and Libre Rio in June 2024. The FDA says Stelo is not for people with problematic low blood sugar and that users should not make medical decisions from its readings without their provider. Avoid smartwatches or rings that claim to measure glucose without piercing the skin; the FDA warns none are authorized.
Our picks at a glance
  • Dexcom Stelo glucose biosensor. Best for: Adults not using insulin who want to see glucose trends. See options on Amazon
  • Abbott Lingo continuous glucose monitor. Best for: Adults without diabetes focused on wellness. See options on Amazon
  • Standard blood glucose meter kit. Best for: Checking a CGM reading with a finger stick. See options on Amazon

Compare the picks and what to watch out for

How a CGM works

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains that a CGM estimates your glucose level every few minutes and tracks it over time. It has a tiny sensor inserted under the skin, often on the belly or arm, held by a sticky patch; a transmitter; and software on a phone or receiver. The sensor estimates glucose in the fluid between cells, which NIDDK says is very similar to blood glucose.

For the over-the-counter Stelo, the FDA says each sensor can be worn up to 15 days and the app presents glucose measurements and trends every 15 minutes. Abbott says its Lingo biosensor is worn on the upper arm for 14 days.

Over-the-counter options compared

SystemIntended forWear time
Dexcom SteloAdults 18+ not using insulin, without problematic hypoglycemiaUp to 15 days per sensor
Abbott LingoConsumers 18+ focused on health and wellness14 days, upper arm
Abbott Libre RioAdults 18+ with Type 2 diabetes not using insulinNot stated in the cited release

Stelo details are from the FDA's March 2024 announcement; Lingo and Libre Rio details are from Abbott's June 2024 announcement of FDA clearance.

Who these devices are not for

The FDA also says users should not make medical decisions based on Stelo's output without talking to their health care provider.

Avoid no-needle glucose watches and rings

In February 2024 the FDA warned consumers not to buy or use smartwatches or smart rings that claim to measure blood glucose without piercing the skin. It said it has not authorized, cleared or approved any smartwatch or smart ring intended to measure or estimate blood glucose on its own, and that these devices are sold under many brand names, including through online marketplaces.

The FDA explains that inaccurate readings can lead people with diabetes to take the wrong dose of insulin or other glucose-lowering medicines, which can quickly cause dangerously low glucose. A watch that displays data from an authorized CGM is different; the warning is about devices that claim to measure glucose themselves. For general wrist trackers, see our fitness tracker band guide.

Living with a sensor

Is an OTC CGM worth it for you?

The FDA described the first OTC CGM as a way for people to better understand how diet and exercise may affect blood sugar, and to buy a CGM without a health care provider's involvement. NIDDK says seeing glucose in real time can help people make more informed decisions about food, activity and medicines.

Makers also make wellness claims that go beyond what the FDA said. Treat app coaching as general guidance, not a diagnosis. If you have diabetes or abnormal readings, involve your doctor, and remember NIDDK notes a finger-stick check with a standard meter may sometimes be needed.

What to look for when you buy

Dexcom Stelo glucose biosensor

Best for: Adults not using insulin who want to see glucose trends

The FDA cleared Stelo as the first OTC CGM; each sensor is worn up to 15 days and readings show every 15 minutes in the app.

Watch out: Not for problematic hypoglycemia; it does not alert to dangerous lows.

See options on Amazon

Abbott Lingo continuous glucose monitor

Best for: Adults without diabetes focused on wellness

Abbott says Lingo's biosensor is worn on the upper arm for 14 days and streams glucose data to a coaching app.

Watch out: Coaching is general guidance; do not make medical decisions without your provider.

See options on Amazon

Standard blood glucose meter kit

Best for: Checking a CGM reading with a finger stick

NIDDK says you may sometimes need to compare CGM readings with a finger-stick test and a standard blood glucose meter.

Watch out: Use test strips made for your meter and follow its instructions.

See options on Amazon
When to talk to a doctor: Do not change diabetes medicines or insulin based on an over-the-counter CGM without your health care provider. The FDA notes dangerously low glucose can cause mental confusion; seek urgent care for symptoms like this.

Questions people ask

Can I buy a continuous glucose monitor without a prescription?
Yes. The FDA cleared Dexcom's Stelo as the first OTC CGM in March 2024, and Abbott announced OTC clearance for Lingo and Libre Rio in June 2024.
Can I use an OTC CGM if I take insulin?
No. Stelo is cleared for people not using insulin. Ask your provider about a prescription CGM.
Do smartwatches measure blood sugar?
No authorized smartwatch or ring measures glucose without piercing the skin, according to the FDA.
How long does a CGM sensor last?
Stelo sensors up to 15 days; Lingo 14 days. NIDDK says disposable sensors generally last 7 to 14 days.
Are there side effects?
The FDA reported local infection, skin irritation and pain or discomfort in the Stelo study.

Sources

Sources checked 2026-10-15.